Joint assessment matters: diagnostic and therapeutic benefits of interdisciplinary psoriasis care
Psoriasis is a chronic inflammatory disease often accompanied by musculoskeletal symptoms and psoriatic arthritis (PsA). Early identification of PsA remains challenging, underscoring the need for interdisciplinary care between dermatology and rheumatology. To evaluate the diagnostic and therapeutic...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 2026
|
| In: |
Advances in therapy
Year: 2026, Pages: 1790-1801 |
| ISSN: | 1865-8652 |
| DOI: | 10.1007/s12325-026-03520-8 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s12325-026-03520-8 |
| Author Notes: | Tassilo Dege, Oliver Steffens, Özlem Kiesel, Iana Bychkova, Lara Leichtfuss, Theresa Schulze-Hagen, Matthias Goebeler, Marc Schmalzing, Jan Leipe, Victor Olsavszky, Patrick-Pascal Strunz, Caroline Glatzel, Astrid Schmieder |
| Summary: | Psoriasis is a chronic inflammatory disease often accompanied by musculoskeletal symptoms and psoriatic arthritis (PsA). Early identification of PsA remains challenging, underscoring the need for interdisciplinary care between dermatology and rheumatology. To evaluate the diagnostic and therapeutic impact of an interdisciplinary dermatology-rheumatology board (IDRB) for patients with psoriasis, we initiated a non-randomized, prospective bicentric study. |
|---|---|
| Item Description: | Online veröffentlicht: 28. Februar 2026 Gesehen am 12.03.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1865-8652 |
| DOI: | 10.1007/s12325-026-03520-8 |